Join Dr. Kevin Davidson, MD, FCCP for an update on autoimmune pulmonary alveolar proteinosis (aPAP), covering pathophysiology, clinical presentation, diagnosis, and management.
Following the presentation, Dr. Jeff Sippel, MD, will moderate a discussion blending clinical insights with the lived experience of Kelsea, a patient advocate living with aPAP.
Date: Monday, May 18th
Time: 1:00 PM to 2:00 PM EDT
Location: Innovation Theater 6 inside the Exhibit Hall
Lunch will be provided by the American Thoracic Society.
Undiagnosed aPAP can increase clinical burden1,2 It takes an average of 18 months for someone to be diagnosed accurately with aPAP.3 When you see1,4,5:
- Common chronic pulmonary symptoms
- An abnormal CT scan
- Pulmonary infections that are refractory to treatment
Then, it’s time to consider testing for GM-CSF autoantibodies.3,6
Visit aPAPClearPath.com/hcp to learn more.
For more details, come to Booth #845 or click the button below.
CT=computerized tomography; GM-CSF=granulocyte-macrophage colony-stimulating factor.
References: 1. Data on file. REF-00012. Savara Inc. 2023. 2. Carey B, Chalk C, Stock J, et al. A dried blood spot test for diagnosis of autoimmune pulmonary alveolar proteinosis. J Immunol Methods. 2022;511:113366. doi:10.1016/j.jim.2022.113366. 3. Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The role of GM-CSF autoantibodies in infection and autoimmune pulmonary alveolar proteinosis: a concise review. Front Immunol. 2021;12:752856. doi:10.3389/fimmu.2021.752856. 4. McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC. Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2018;13(1):129-133. doi:10.1186/s13023018-0846-y. 5. Miyashita K, Hozumi H, Inoue Y, Suzuki T, Suda T. Nationwide survey of adult patients with pulmonary alveolar proteinosis using the National Database of designated intractable diseases of Japan. Respir Investig. 2023;61(3):364-370. doi:10.1016/j.resinv.2023.02.011. 6. McCarthy C, Kokosi M, Bonella F. Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis. Curr Opin Pulm Med. 2019;25(5):450-458. doi:10.1097/MCP.0000000000000601.

© 2026 Savara Inc. All rights reserved.
US-SAV-0078 03/26


